INSMED Inc SEC filings INSM
INSMED Inc has 1,011 filings in SEC EDGAR's recent list, going back to May 19, 2017. Its latest annual report, Form ARS, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 1, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Feb 19, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 4, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Feb 20, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Feb 22, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 23, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 17, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Feb 25, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Feb 25, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Feb 22, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Feb 23, 2018 | Dec 31, 2017 |
Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INSM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- VA
- Headquarters
- Bridgewater, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1104506
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.